EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro

Xiaojia Guo, Lei Zhao, Wei Li, Ruiyuan Cao, Wu Zhong iD

Viruses · 2024

DOI: 10.3390/v16091467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Xiaojia Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China. Hauptthemen laut MEDLINE: Dibenzothiepins, Antiviral Agents, Triazines, Drug Synergism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China, National Science and Technology Major Projects “Major New Drugs Innovation and Development”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza viruses remain a major threat to human health. Four classes of drugs have been approved for the prevention and treatment of influenza infections. Oseltamivir, a neuraminidase inhibitor, is a first-line anti-influenza drug, and baloxavir is part of the newest generation of anti-influenza drugs that targets the viral polymerase. The emergence of drug resistance has reduced the efficacy of established antiviral drugs. Combination therapy is one of the options for controlling drug resistance and enhancing therapeutical efficacies. Here, we evaluate the antiviral effects of baloxavir combined with neuraminidase inhibitors (NAIs) against wild-type influenza viruses, as well as influenza viruses with drug-resistance mutations. The combination of baloxavir with NAIs led to significant synergistic effects; however, the combination of baloxavir with laninamivir failed to result in a synergistic effect on influenza B viruses. Considering the rapid emergence of drug resistance to baloxavir, we believe that these results will be beneficial for combined drug use against influenza.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DibenzothiepinsAntiviral AgentsTriazinesDrug SynergismMorpholinesPyridonesNeuraminidaseEnzyme InhibitorsDrug Resistance, ViralHumansInfluenza B virusAnimalsPyridinesThiazolesGuanidinesOrthomyxoviridaeDogsMadin Darby Canine Kidney CellsInfluenza, HumanSialic AcidsInfluenza A virusThiepinsTriazolesBenzimidazolesPyrans

Stichwörter der Autor:innen

baloxavirdrug combinationdrug-resistant strainsinfluenza virusneuraminidase inhibitors

Substanzen

baloxavirDibenzothiepinsAntiviral AgentsTriazinesMorpholinesPyridonesNeuraminidaseEnzyme InhibitorsPyridinesThiazoles

Autor:innen und Institutionen

  • National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
  • Beijing Sunho Pharmaceutical Co., Ltd., Beijing 102600, China.

ORCID-Profile: Wu Zhong

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • National Science and Technology Major Projects “Major New Drugs Innovation and Development”

Zitieren

APA

Guo, X., Zhao, L., Li, W., Cao, R., & Zhong, W. (2024). The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro. Viruses. https://doi.org/10.3390/v16091467

Vancouver

Guo X, Zhao L, Li W, Cao R, Zhong W. The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro. Viruses. 2024. doi:10.3390/v16091467

BibTeX
@article{Guo2024,
  author = {Guo, Xiaojia and Zhao, Lei and Li, Wei and Cao, Ruiyuan and Zhong, Wu},
  title = {The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091467}
}
Kostenlos starten →